Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study
To assess the diagnostic utility of corneal confocal microscopy (CCM) for diabetic peripheral neuropathy (DPN) and the risk factors for corneal nerve loss. A total of 490 participants, including 72 healthy control subjects, 149 with type 1 diabetes, and 269 with type 2 diabetes, underwent detailed a...
Saved in:
Published in | Diabetes care Vol. 44; no. 1; pp. 150 - 156 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Diabetes Association
01.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To assess the diagnostic utility of corneal confocal microscopy (CCM) for diabetic peripheral neuropathy (DPN) and the risk factors for corneal nerve loss.
A total of 490 participants, including 72 healthy control subjects, 149 with type 1 diabetes, and 269 with type 2 diabetes, underwent detailed assessment of peripheral neuropathy and CCM in relation to risk factors.
Corneal nerve fiber density (CNFD) (
< 0.0001 and
< 0.0001), corneal nerve fiber branch density (CNBD) (
< 0.0001 and
< 0.0001), and corneal nerve fiber length (CNFL) (
< 0.0001 and
= 0.02) were significantly lower in patients with type 1 and type 2 diabetes compared with control subjects. CNFD (
< 0.0001), CNBD (
< 0.0001), and CNFL (
< 0.0001) were lower in type 1 diabetes compared with type 2 diabetes. Receiver operating characteristic curve analysis for the diagnosis of DPN demonstrated a good area under the curve for CNFD of 0.81, CNBD of 0.74, and CNFL of 0.73. Multivariable regression analysis showed a significant association among reduced CNFL with age (β = -0.27,
= 0.007), HbA
(β = -1.1;
= 0.01), and weight (β = -0.14;
= 0.03) in patients with type 2 diabetes and with duration of diabetes (β = -0.13;
= 0.02), LDL cholesterol (β = 1.8,
= 0.04), and triglycerides (β = -2.87;
= 0.009) in patients with type 1 diabetes.
CCM identifies more severe corneal nerve loss in patients with type 1 diabetes compared with type 2 diabetes and shows good diagnostic accuracy for DPN. Furthermore, the risk factors for a reduction in corneal nerve fiber length differ between type 1 and type 2 diabetes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0149-5992 1935-5548 1935-5548 |
DOI: | 10.2337/dc20-1482 |